Copyright
©The Author(s) 2016.
World J Exp Med. Feb 20, 2016; 6(1): 21-36
Published online Feb 20, 2016. doi: 10.5493/wjem.v6.i1.21
Published online Feb 20, 2016. doi: 10.5493/wjem.v6.i1.21
Figure 1 Staging and possible strategy to treat patients with hcc and liver cirrhosis.
PS: Performance status according to ECOG; BCLC: Barcelona clinic liver cancer; HVPG: Hepatic vein portal gradient; BSC: Best supportive care; CP: Child-Pugh score; CK19: Cytokeratin 19; S2: Patients beyond Milan Criteria (see text). References[73-75,79,123].
- Citation: Mazzanti R, Arena U, Tassi R. Hepatocellular carcinoma: Where are we? World J Exp Med 2016; 6(1): 21-36
- URL: https://www.wjgnet.com/2220-315X/full/v6/i1/21.htm
- DOI: https://dx.doi.org/10.5493/wjem.v6.i1.21